Dan Karlin - Jan 1, 2022 Form 3 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Chief Medical Officer
Signature
/s/ Robert Barrow, Attorney-in-Fact
Stock symbol
MNMD
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 08:29 PM
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MNMD Subordinate Voting Shares 3.29M Jan 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 1.47M $2.42 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,130,000 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest as to 25% on February 26, 2022, and the remainder vest in 36 equal monthly installments beginning on March 25, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F2 25% of the shares underlying the option shall vest and become exercisable on February 26, 2022; the remaining shares underlying the option shall vest and become exercisable in 36 equal monthly installments beginning on February 26, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F3 The option grant has an exercise price of $3.08 Canadian Dollars. This represents the exercise price in United States Dollars.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney